Skip to content

Clinical trials

Phase 1 Diabetic Retinopathy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Retinopathy Phase: Phase 1 Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20032
20051
20065
20073
20084
20091
20101
20122
20153
20162
20182
20191
20202
20224
20241
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Recruiting5
Unknown status5
Terminated2
Withdrawn1
Enrolling by invitation1
Not yet recruiting1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Eye Institute (NEI)5
Medical College of Wisconsin2
National Taiwan University Hospital2
ThromboGenics2
Aerie Pharmaceuticals1
Heidelberg University1
Hermann Eye Center1
Hoffmann-La Roche1
Iran University of Medical Sciences1
Manhattan Eye, Ear & Throat Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Retinopathy40
Diabetes Mellitus8
Macular Edema7
Macular Degeneration6
Retinal Diseases5
Choroidal Neovascularization3
Retinal Vein Occlusion3
Diabetes Mellitus, Type 22
Inflammation2
Retinitis Pigmentosa2

Trials

Showing 76 to 40 of 40. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.